Asthma Clinical Trials in San Antonio

Showing 121-140 of 278 trials

Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

NCT02593071

This study will enroll subjects who received the RSV F vaccine or placebo in the earlier study (RSV-E-201, Year 1) and re-randomize them to receive either vaccine or placebo in a second season. This design will permit evaluation of the safety and immunogenicity of revaccination in a second RSV season, and the safety and immunogenicity of revaccination over two years.

Respiratory Syncytial Virus (RSV)

Novavax1,330 participantsStarted Oct 2015

Redding, California, United States • Stockbridge, Georgia, United States • Lenexa, Kansas, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids

NCT01090024

To investigate the effectiveness and safety of BI 671800 given in the morning (AM), evening (PM) or twice daily (b.i.d.) compared too placebo as add on therapy to inhaled corticosteroid in symptomatic asthma patients.

Asthma

Boehringer Ingelheim108 participantsStarted Mar 2010

Huntington Beach, California, United States • Mission Viejo, California, United States • Stockton, California, United States +11 more locations

Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.

Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids

Asthma Trials in Other Cities

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.

Tolerability and Efficacy of RJX in Patients With COVID-19

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children

Plasma Adsorption in Patients With Confirmed COVID-19

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Other Conditions in San Antonio